Recombinant Danio rerio Transmembrane protein 18 (tmem18) is a protein derived from the zebrafish (Danio rerio) and produced using an in vitro E. coli expression system. This recombinant protein is available for research purposes, offering a tool for studying the biological functions and mechanisms of tmem18 in various contexts, including obesity and metabolic regulation.
Production Method: The recombinant tmem18 is produced in an in vitro E. coli expression system, which allows for high purity and controlled production conditions .
Source: The protein is sourced from Danio rerio, a model organism commonly used in scientific research due to its genetic similarity to humans and ease of manipulation.
Purity and Quality: The product is described as having high purity, which is crucial for reliable experimental results.
TMEM18 is known to be associated with obesity and body mass index (BMI) in humans. It encodes a sequence-specific DNA-binding protein and has been implicated in the central control of body weight through interactions with nuclear pore proteins . In zebrafish, similar mechanisms might exist, although specific studies on the zebrafish version are less detailed.
Obesity and Metabolic Studies: The recombinant tmem18 can be used to study the role of TMEM18 in obesity and metabolic regulation, potentially offering insights into how this protein influences body weight and energy balance.
Protein-Protein Interactions: Similar to its human counterpart, zebrafish tmem18 might interact with nuclear pore proteins, which could be explored using biochemical assays like co-immunoprecipitation or affinity purification .
While specific data on the recombinant Danio rerio tmem18 is limited, studies on the human TMEM18 provide a framework for potential research directions:
Future studies could focus on:
Functional Characterization: Investigating the specific roles of zebrafish tmem18 in metabolic regulation and obesity.
Comparative Studies: Comparing the functions and interactions of human and zebrafish TMEM18 to identify conserved mechanisms.
Therapeutic Applications: Exploring whether insights from zebrafish models could inform therapeutic strategies for obesity-related disorders.
Danio rerio tmem18 is a small protein of 152 amino acids that belongs to the transmembrane protein 18 family (IPR026721). Unlike previous models suggesting three transmembrane domains, recent structural analyses indicate tmem18 likely contains four transmembrane domains . The protein is predominantly alpha-helical in structure. In zebrafish, tmem18 is encoded by a protein-coding gene located on chromosome 23 . The protein contains a positively charged C-terminus that includes a nuclear localization signal, which is critical for its DNA-binding functionality .
Tmem18 in zebrafish is predicted to enable DNA binding activity and plays a role in fat cell differentiation pathways . The protein primarily localizes to the nuclear membrane where it can bind to DNA in a sequence-specific manner . This binding activity brings chromatin very close to the nuclear membrane, potentially repressing transcription of target genes . Additionally, tmem18 has been found to physically interact with key components of the nuclear pore complex, suggesting a role in nucleocytoplasmic transport or chromatin organization .
In Danio rerio, tmem18 expression has been documented in multiple tissues, including:
This expression pattern suggests tmem18 may have tissue-specific functions across different physiological systems in zebrafish.
For producing recombinant Danio rerio tmem18, researchers should consider several expression systems based on the protein's characteristics:
Bacterial Expression System (E. coli):
For DNA-binding domain studies, a C-terminal fragment containing the positively charged region can be expressed as a fusion protein with tags like 6xHis or GST
Culture conditions: LB medium supplemented with appropriate antibiotics
Induction: 0.5-1.0 mM IPTG at OD600 of 0.6-0.8
Temperature: Lower temperature (16-25°C) during induction to enhance proper folding
Challenge: Full-length tmem18 with multiple transmembrane domains may form inclusion bodies
Eukaryotic Expression Systems:
Insect cells (Sf9, Sf21) using baculovirus expression system
Mammalian cells (HEK293, CHO) for studies requiring mammalian post-translational modifications
Yeast (Pichia pastoris) for membrane protein expression
The choice of expression system should be guided by the specific research questions and downstream applications.
Purification Protocol for Recombinant tmem18:
Cell Lysis and Membrane Fraction Isolation:
For full-length protein: Gentle lysis methods to preserve membrane integrity
Buffer composition: 50 mM Tris-HCl (pH 7.5), 150 mM NaCl, 1 mM EDTA, protease inhibitor cocktail
Ultracentrifugation at 100,000 × g to isolate membrane fractions
Membrane Protein Solubilization:
Detergents: n-dodecyl-β-D-maltoside (DDM), digitonin, or CHAPSO at 1-2% w/v
Incubation: 1-2 hours at 4°C with gentle rotation
Affinity Chromatography:
For His-tagged proteins: Ni-NTA resin
For GST-fusion proteins: Glutathione Sepharose
Imidazole gradient elution (20-250 mM) for His-tagged proteins
Size Exclusion Chromatography:
Buffer: 20 mM Tris-HCl (pH 7.4), 150 mM NaCl, 0.05-0.1% detergent
Columns: Superdex 75 or 200 depending on construct size
For the DNA-binding domain alone (C-terminus), standard protein purification methods may be suitable without requiring detergent solubilization.
To characterize the DNA-binding specificity of recombinant Danio rerio tmem18, researchers should employ multiple complementary approaches:
Electrophoretic Mobility Shift Assay (EMSA):
Generate purified recombinant tmem18 or its C-terminal DNA-binding domain
Design oligonucleotide probes based on predicted binding sequences
Incubate protein with labeled DNA probes
Analyze mobility shifts on non-denaturing polyacrylamide gels
Perform competition assays with unlabeled DNA to confirm specificity
Chromatin Immunoprecipitation (ChIP):
Express epitope-tagged tmem18 in zebrafish cells or embryos
Cross-link protein-DNA complexes with formaldehyde
Immunoprecipitate with antibodies against the epitope tag
Identify bound DNA sequences through sequencing (ChIP-seq)
Systematic Evolution of Ligands by Exponential Enrichment (SELEX):
Incubate recombinant tmem18 with a random oligonucleotide library
Isolate protein-DNA complexes
Amplify bound DNA by PCR
Repeat selection processes for multiple rounds
Sequence enriched DNA to identify consensus binding motifs
Reporter Gene Assays:
Clone potential tmem18 binding sequences upstream of a reporter gene
Co-transfect with tmem18 expression vector
Measure reporter gene activity to assess transcriptional effects
Previous research has demonstrated that TMEM18 can suppress expression from a reporter vector containing its target sequence , suggesting that similar approaches could be effective for the zebrafish ortholog.
To investigate the interaction between tmem18 and the nuclear pore complex (NPC) in Danio rerio, researchers can employ several techniques:
Co-immunoprecipitation (Co-IP):
Generate antibodies against tmem18 or use epitope-tagged recombinant protein
Prepare nuclear membrane fractions from zebrafish tissues or cells
Immunoprecipitate tmem18 and identify interacting NPC components by mass spectrometry
Validate interactions by reciprocal Co-IP with antibodies against NPC components
Proximity Ligation Assay (PLA):
Fix zebrafish cells or tissue sections
Incubate with primary antibodies against tmem18 and specific NPC proteins
Use secondary antibodies conjugated with DNA oligonucleotides
Perform ligation and rolling circle amplification
Visualize interaction signals by fluorescence microscopy
Fluorescence Resonance Energy Transfer (FRET):
Generate fusion constructs of tmem18 and NPC components with appropriate fluorophores
Express in zebrafish cells or embryos
Measure energy transfer to detect protein-protein proximity
BioID or APEX Proximity Labeling:
Generate fusion constructs of tmem18 with BioID or APEX2
Express in zebrafish cells
Activate biotinylation of proteins in proximity to tmem18
Purify biotinylated proteins and identify by mass spectrometry
To study tmem18's role in adipogenesis and metabolism in zebrafish, researchers can implement the following experimental approaches:
Genetic Manipulation:
CRISPR-Cas9 Gene Editing:
Design sgRNAs targeting zebrafish tmem18
Generate knockout or knockin lines
Assess phenotypes related to adiposity and lipid metabolism
Morpholino Knockdown:
Design splice-blocking or translation-blocking morpholinos
Inject into one-cell stage embryos
Analyze early developmental effects on adipose tissue formation
Transgenic Overexpression:
Generate tissue-specific promoter-driven tmem18 constructs
Create stable transgenic lines with adipose tissue or brain-specific expression
Assess effects on adipogenesis and whole-body metabolism
Phenotypic Analysis:
Adipose Tissue Visualization:
Nile Red or Oil Red O staining to visualize neutral lipids
Fluorescent lipid analogs for in vivo imaging
Transgenic lines with fluorescently labeled adipocytes
Metabolic Parameters:
Whole-body triglyceride and cholesterol quantification
Glucose tolerance tests
Oxygen consumption and activity measurements
Gene Expression Analysis:
qPCR for adipogenesis markers (pparγ, cebpα, fabp11a)
RNA-seq to identify genome-wide expression changes
In situ hybridization to localize expression in tissues
Dietary Interventions:
High-Fat Diet Challenge:
Feed wild-type and tmem18-modified fish with high-fat diets
Compare weight gain, adipose tissue expansion, and metabolic parameters
Analyze gene expression changes in response to diet
Based on mouse studies, researchers should pay particular attention to food intake and energy expenditure, as loss of Tmem18 in mice results in increased body weight (exacerbated by high-fat diet) due to increased food intake, while overexpression reduces food intake and increases energy expenditure .
Given tmem18's expression in the nervous system and its potential role in energy balance regulation through central mechanisms , researchers can employ these approaches:
Neuroanatomical Studies:
Expression Mapping:
In situ hybridization to precisely localize tmem18 expression in brain regions
Immunohistochemistry to detect protein distribution
Single-cell RNA-seq to identify neuron populations expressing tmem18
Neuronal Circuit Analysis:
Transgenic reporter lines to visualize tmem18-expressing neurons
Anterograde and retrograde tracing to map connections
Calcium imaging to assess neuronal activity
Functional Studies:
Neuron-Specific Manipulation:
Conditional knockdown or overexpression using neuron-specific promoters
Optogenetic or chemogenetic activation/inhibition of tmem18-expressing neurons
Focal brain region injection of viral vectors for localized manipulation
Behavioral Assays:
Feeding behavior quantification
Activity and energy expenditure measurements
Responses to metabolic challenges (fasting, refeeding)
Molecular Mechanisms:
Transcriptional Profiling:
RNA-seq of specific brain regions after tmem18 manipulation
ChIP-seq to identify direct target genes in neurons
Analysis of neuropeptide expression changes
Signaling Pathway Analysis:
Investigation of interaction with known energy balance pathways
Protein-protein interaction studies in neuronal contexts
Phosphorylation state analysis following nutritional challenges
The literature presents contradictions regarding tmem18's transmembrane topology, with earlier work suggesting three transmembrane domains while more recent evidence indicates four transmembrane domains . To resolve this contradiction, researchers should:
Computational Prediction Refinement:
Apply multiple prediction algorithms (TMHMM, Phobius, HMMTOP)
Compare results across algorithms and across species orthologs
Generate consensus topology models
Experimental Validation Approaches:
Substituted Cysteine Accessibility Method (SCAM):
Generate cysteine mutants throughout the protein sequence
Express in membrane systems
Probe accessibility with membrane-permeable and impermeable reagents
Map topology based on reactivity patterns
Protease Protection Assays:
Express epitope-tagged versions of tmem18 in cell systems
Prepare microsomes or membrane fractions
Treat with proteases with/without membrane permeabilization
Detect protected fragments by Western blotting
Glycosylation Mapping:
Insert glycosylation sites at various positions
Express in eukaryotic systems
Assess glycosylation status to determine luminal exposure
Cryo-EM or X-ray Crystallography:
Purify sufficient quantities of stable, homogeneous protein
Determine high-resolution structure to definitively resolve topology
Validation in Zebrafish System:
Generate fusion constructs with reporters positioned at different segments
Express in zebrafish cells or tissues
Determine subcellular localization and membrane topology in vivo
To comprehensively identify genome-wide binding sites and transcriptional targets of tmem18 in zebrafish, researchers should implement an integrated approach:
ChIP-seq Analysis:
Generate epitope-tagged tmem18 constructs (HA, FLAG, or V5)
Express in zebrafish embryos or cell lines
Perform chromatin immunoprecipitation followed by high-throughput sequencing
Analyze binding sites with peak calling algorithms
Identify enriched sequence motifs and genomic features
CUT&RUN or CUT&Tag:
Use antibodies against tmem18 or epitope tags
Perform targeted DNA cleavage around binding sites
Sequence released fragments
Compare with ChIP-seq results for validation
ATAC-seq Combined with tmem18 Manipulation:
Generate tmem18 knockdown, knockout, or overexpression models
Perform ATAC-seq to identify changes in chromatin accessibility
Correlate changes with potential tmem18 binding sites
RNA-seq for Transcriptional Effects:
Manipulate tmem18 levels (knockdown, knockout, overexpression)
Perform RNA-seq to identify differentially expressed genes
Compare with binding site data to distinguish direct from indirect targets
Validate key targets with qPCR and reporter assays
Integrated Data Analysis:
Correlate binding sites with gene expression changes
Perform pathway and Gene Ontology enrichment analyses
Construct regulatory networks centered on tmem18
Compare with known obesity and metabolism-related pathways
This integrated approach would provide comprehensive insights into the regulatory functions of tmem18 in zebrafish and could reveal mechanisms by which TMEM18 genetic variation contributes to obesity risk in humans .
Studies indicate significant conservation of tmem18 structure and function across vertebrates, including between zebrafish and mammals:
Sequence and Structural Conservation:
| Species | Protein Length | Sequence Identity to Human* | Predicted Transmembrane Domains |
|---|---|---|---|
| Human (H. sapiens) | 140 aa | 100% | 4 |
| Mouse (M. musculus) | 140 aa | ~98% | 4 |
| Zebrafish (D. rerio) | 152 aa | ~78% | 4 |
| *Approximate values based on available data |
Functional Conservation:
Nuclear Membrane Localization: Both zebrafish and mammalian tmem18 localize to the nuclear membrane
DNA Binding Activity: The DNA-binding capability appears conserved, mediated by the positively charged C-terminus
Metabolic Regulation: In mice, Tmem18 influences body weight, food intake, and energy expenditure , which likely extends to zebrafish given the conservation of adipogenic pathways
Expression Patterns: Both zebrafish and mammalian tmem18 are expressed in the nervous system and metabolically active tissues
Model System Complementarity:
Zebrafish offers advantages for high-throughput screening, developmental studies, and in vivo imaging
Mouse models provide closer physiological relevance to human metabolism
Cell culture systems from both species can interrogate molecular mechanisms
Researchers should consider the strengths of each model system when designing experiments to study tmem18 function, with zebrafish particularly valuable for early developmental processes and genetic screens.
Zebrafish tmem18 research can provide valuable insights into human obesity genetics through several approaches:
Functional Validation of Human Variants:
Identify human GWAS variants near TMEM18 associated with obesity
Generate corresponding mutations in zebrafish tmem18
Assess phenotypic consequences on adiposity and metabolism
Test whether human variants can rescue zebrafish tmem18 mutant phenotypes
Regulatory Network Mapping:
Identify downstream targets of tmem18 in zebrafish
Determine conservation of these pathways in humans
Assess whether these target genes contain obesity-associated variants
Construct network models connecting TMEM18 to broader metabolic regulation
Drug Discovery Applications:
Develop zebrafish-based screening platforms for tmem18 modulators
Test compounds affecting tmem18 function or expression
Validate hits in mammalian systems
Identify potential therapeutic targets for obesity
Developmental Origins:
Track tmem18 expression during zebrafish development
Identify critical periods for metabolic programming
Correlate with human developmental patterns
Explore early interventions targeting tmem18 pathways
Given the strong and reproducible association between TMEM18 genetic variants and obesity in humans , and evidence that TMEM18 itself (rather than adjacent genes) mediates effects on adiposity through central nervous system action , zebrafish models offer a valuable system for mechanistically dissecting these relationships.
RNA Extraction and Quality Control:
Tissue Preparation:
Flash-freeze dissected tissues in liquid nitrogen
For whole embryos: Pool 20-30 embryos per developmental stage
For adult tissues: Carefully dissect specific regions (brain, liver, adipose, etc.)
RNA Isolation:
TRIzol extraction followed by column purification
DNase treatment to remove genomic DNA contamination
Quality assessment by spectrophotometry (A260/A280 ratio) and gel electrophoresis
For small samples: Use RNA extraction kits optimized for limited material
Quantitative RT-PCR:
Primer Design:
Design intron-spanning primers to avoid genomic DNA amplification
Optimal tmem18 primers: Forward 5'-[sequence based on zebrafish tmem18]-3', Reverse 5'-[sequence based on zebrafish tmem18]-3'
Amplicon size: 80-150 bp for optimal qPCR efficiency
Reference Genes:
Use multiple reference genes (ef1α, rpl13a, actb1)
Verify stability across experimental conditions
Apply geometric averaging for normalization
Reaction Conditions:
Two-step RT-PCR protocol
cDNA synthesis: 500ng total RNA per 20μl reaction
qPCR cycling: Initial denaturation (95°C, 3 min), followed by 40 cycles of 95°C for 15s and 60°C for 30s
In Situ Hybridization:
Probe Design:
Generate antisense RNA probes (400-800 bp) targeting tmem18 mRNA
Include sense probes as negative controls
Protocol Optimization:
Fixation: 4% paraformaldehyde, 4-16 hours depending on sample size
Proteinase K treatment: Titrate concentration (5-10 μg/ml) and time (5-30 minutes) based on developmental stage
Hybridization temperature: 65-70°C for RNA probes
Anti-DIG antibody concentration: 1:2000-1:5000 dilution
Generating effective antibodies against transmembrane proteins like zebrafish tmem18 presents several challenges:
Solution: Target the C-terminal domain (known to be exposed and functionally important)
Design synthetic peptides corresponding to hydrophilic, exposed regions
Use protein structure prediction to identify optimal epitopes
Solution: Express recombinant fragments rather than full-length protein
Focus on the DNA-binding C-terminal domain for antibody generation
Consider native conformation during immunization strategies
Solution: Compare sequences with other zebrafish proteins to identify unique regions
Test antibody specificity against tmem18-knockout samples as negative controls
Perform peptide competition assays to verify specificity
Solution: Use signal amplification methods for detection
Implement tyramide signal amplification for immunohistochemistry
Consider concentrated samples (nuclear fractions) for Western blotting
Recommended Approach:
Generate multiple antibodies against different epitopes
Use both polyclonal and monoclonal approaches
Validate with multiple techniques (Western blot, immunoprecipitation, immunohistochemistry)
Consider epitope tags in recombinant studies when native antibodies are challenging
Several cutting-edge technologies show promise for advancing tmem18 research in zebrafish:
Single-Cell Multi-Omics:
Single-cell RNA-seq to identify cell populations expressing tmem18
Single-cell ATAC-seq to map chromatin accessibility changes
Spatial transcriptomics to preserve tissue context while profiling expression
Integration of multiple data types to build comprehensive regulatory models
Advanced Genome Editing:
Prime editing for precise modification of tmem18 sequences
Base editing for introducing specific point mutations
Inducible CRISPR systems for temporal control of gene modification
Tissue-specific Cas9 expression for targeted manipulation
Live Imaging Technologies:
Lattice light-sheet microscopy for high-resolution, low-phototoxicity imaging
Optogenetic tools combined with calcium imaging to manipulate and monitor tmem18-expressing neurons
FRET-based sensors to detect protein-protein interactions in vivo
Expansion microscopy for super-resolution imaging of subcellular structures
Protein Structure and Interaction Analysis:
AlphaFold2 and related AI methods for structure prediction
Cryo-electron tomography for visualizing nuclear membrane complexes
Proximity labeling methods (TurboID, APEX) for mapping protein interaction networks
High-throughput screening of chemical modulators of tmem18 function
These technologies could help resolve outstanding questions about tmem18's precise molecular function, regulatory networks, and role in obesity pathogenesis.
Understanding the molecular mechanisms of tmem18 function could contribute to obesity therapeutics through several pathways:
Target Identification:
Characterization of the transcriptional network regulated by tmem18
Identification of downstream effectors mediating metabolic effects
Discovery of proteins interacting with tmem18 at the nuclear pore complex
Mapping of signaling pathways connecting tmem18 to appetite regulation
Therapeutic Strategies:
Small Molecule Development:
Compounds modulating tmem18 DNA-binding activity
Molecules affecting tmem18 interaction with the nuclear pore complex
Agents regulating tmem18 expression in specific tissues
Gene Therapy Approaches:
Targeted delivery of tmem18 to hypothalamic neurons
CRISPR-based modulation of tmem18 expression
Correction of obesity-associated regulatory variants
Precision Medicine Applications:
Genetic screening for TMEM18 variants to personalize interventions
Biomarkers based on tmem18 pathway activity
Targeted interventions for specific genetic subgroups
Given that TMEM18 functions within the central nervous system to influence food intake and energy expenditure , therapeutic approaches targeting these pathways could represent a novel strategy for obesity treatment.